运动预处理对大鼠心肌CuZn-SOD基因表达的影响

为探讨在高原或仿高原环境下高强度运动的心脏适应机制,通过动物实验模拟高原运动心脏,观察了心肌组织中CuZn-sODmRNA的表达情况.结果表明,在海拔5000米环境下,大鼠6%负重游泳10分钟,常压休息10分钟,重复3次,在运动后30分钟和24小时,心肌CuZn-SODmRNA的表达出现两个高峰,分别比对照组升高了47%和112%;而大鼠在单独低压氧环境下不运动,只在缺氧后30分钟时有CuZn-SODmRNA的表达增高.结果提示与经典的缺血预处理类似,在高原或仿高原环境下进行高强度训练,很可能是一种由心肌缺血和缺氧等因素所诱发的"运动预处理”现象.     

静脉注射三乙醇胺对SD大鼠的病理性损伤作用

目的 观察静脉注射三乙醇胺后SD大鼠的组织病理学改变及其可逆性。方法 60只SD大鼠,随机分为对照组和300 mg/kg剂量组,连续30 d给药和恢复4周,分别进行大体解剖和组织病理学检查。结果 连续给药30 d,SD大鼠肝细胞嗜酸性变,肾髓质肾小管上皮细胞变性,脾小体生发中心增大,白髓边缘带增宽,淋巴结内淋巴滤泡数量增多,生发中心增大;恢复4周,肝脏、脾脏和淋巴结病变恢复不明显。结论 静脉注射一定剂量的三乙醇胺,对SD大鼠肝脏、肾脏、脾脏和淋巴结有一定的损伤作用,其中,肾脏的损伤可逆,脾脏、淋巴结和肝脏的损伤有一定程度的恢复。     

培氟沙星治疗细菌感染性疾病96例疗效观察

用法国罗纳．普朗克．乐安公司生产的培氟沙星治疗细菌感染性疾病９６例，结果表明该药对泌尿系统，呼吸系统，消化系统和中枢神经系统等的细菌感染有较好疗效，临床总有效率为８３．３％，９６例患者中检菌阳性８１例，治疗后５８例阴转，细菌阴转率７１．６％，且无明显副作用，值得推广。     

Bexarotene协同TRAIL对白血病细胞株KG1a的凋亡诱导作用

目的 探讨bexarotene联合肿瘤坏死因子相关凋亡诱导配体(TRAIL)对白血病细胞株KG1a凋亡的影响,并初步探讨其作用机制.方法 取对数生长期KG1a,根据不同处理方式分为TRAIL组、bexarotene组、300 ng/mL TRAIL联合bexarotene组和2.0 μmol/L bexaroten联合TRAIL组.流式细胞仪检测各组细胞凋亡率.以先加bexarotene或TRAIL孵育,后加TRAIL或bexarotene处理设计序贯实验,流式细胞仪检测细胞凋亡率.Western blotting分析KG1a细胞型自杀相关因子(Fas)相关死亡域样白介素-1β转换酶抑制蛋白(c-FLIP)表达变化.结果 TRAIL和bexarotene组的各浓度组间(bexarotene 2.0 μmol/L除外)细胞凋亡率比较,差异无统计学意义(P>0.05);两联合用药组的细胞凋亡率均明显高于相应浓度的TRAIL组和bexarotene组(P<0.01).序贯实验表明,bexarotene具有逆转 KG1a对TRAIL耐药的作用(P<0.001).与2.0 μmol/L bexarotene 或300 ng/mL TRAIL 单独用药比较,两者联合应用能显著下调c-FLIP表达(P<0.05).结论 Bexarotene能显著增强TRAIL对KG1a的诱导凋亡作用,下调c-FLIP表达是协同作用的可能机制.     

Norplant皮下埋植避孕剂与Vcu200宫内节育器5年临床对比观察

为指导育龄妇女选用适宜的避孕方法 ,采用统一的接受标准 ,共接收Norplant使用者 3 1 5例 ,Vcu2 0 0使用者 3 2 0例 ,每 6个月随访 1次 ,直至 5年使用期满或终止使用。用生命表法统计 2组间各种事件率 ,使用WHO的MDS软件统计月经日记卡并分析出血类型 ,对 2组间的差异行统计学检验。结果显示 :Norplant使用者 5年持续使用率和因妊娠、月经问题、医学问题、避孕器反应的终止率分别为 80 .0 7%、0 .3 5 %、1 3 .3 7%、6.1 2 %和 0 .46% ;Vcu2 0 0组分别为 84.42 %、9.5 0 %、1 .71 %、0 .3 7%和 4.40 %。阴道出血类型分析显示 ,Norplant组不规则出血者占 43 .1 %～5 7.6% ,使用 6个月后阴道出血基本正常者占 1 2 .9%～ 3 2 .7% ;Vcu2 0 0组出血基本正常者可达 5 4.8%～ 60 .2 %。结果表明 :Norplant埋植剂和Vcu2 0 0节育器具有相同的持续使用率 ,使用Norplant埋植剂后的妊娠率和脱出率明显低于Vcu2 0 0节育器 ,而阴道出血类型中不规则出血明显高于Vcu2 0 0节育器。提示 :2种避孕方法各有优缺点     

被覆自体微粒皮的辐照氟银猪皮移植治疗深度烧伤15例报告

OBJECTIVE: To study the feasibility of using irradiated porcine skin impregnated with fluorine and silver covered by autogenous skin granule graft in the treatment of severe burn injury. METHODS: Autogenous split-thick skin grafts were cut into small pieces (<1 mm3), which were transferred onto the sheet of porcine skin mounted with a layer of Xinnaxing ointment (2 mm in thickness). After eschar removal, the burn wound was covered with the prepared porcine skin, sutured and fixed with small holes at the lower site for drainage. The growth of autogenous granule skin was then observed and the criteria for therapeutic effect evaluation drafted. RESULTS: The layer of Xinnaxing ointment on the the porcine skin improved the adhesion of the autogenous small skin grafts, therefore full use could be made of the donor skin source. In the 15 patients receiving this treatment, the graft-covered area was (12.3+/-3.5) % that of the wound, with the donor-recipient area ratio of 1: (11.0+/-2.7) and subsequent healing time of 27.5+/-5.5 d. Primary healing was achieved in 9 cases, and secondary healing in 6, demonstrating similar clinical effect to that of allo-skin grafting. CONCLUSION: The method is easy and economic, which saves autogenous skin source and produces satisfactory clinical effect.     

Microfluidic analysis of cellular deformability of normal and oxidatively damaged red blood cells

Microfluidic analysis of blood has potential clinical value for determining normal and abnormal erythrocyte deformability. To determine if a microfluidic device could reliably measure intra‐ and inter‐personal variations of normal and oxidized human red blood cell (RBC), venous blood samples were collected from repeat donors over time. RBC deformability was defined by the cortical tension (pN/µm), as determined from the threshold pressure required to deform RBC through 2–2.5 μm funnel‐shaped constrictions. Oxidized RBC were prepared by treatment with phenazine methosulphate (PMS; 50 µM). Analysis of the control and oxidized RBC demonstrated that the microfluidic device could clearly differentiate between normal and mildly oxidized (20.13 ± 1.47 versus 27.51 ± 3.64 pN/µm) RBC. In vivo murine studies further established that the PMS‐mediated loss of deformability correlated with premature clearance. Deformability variation within an individual over three independent samplings (over 21 days) demonstrated minimal changes in the mean pN/µm. Moreover, inter‐individual variation in mean control RBC deformability was similarly small (range: 19.37–21.40 pN/µm). In contrast, PMS‐oxidized cells demonstrated a greater inter‐individual range (range: 25.97–29.90 pN/µm) reflecting the differential oxidant sensitivity of an individual's RBC. Importantly, similar deformability profiles (mean and distribution width; 20.49 ± 1.67 pN/µm) were obtained from whole blood via finger prick sampling. These studies demonstrated that a low cost microfluidic device could be used to reproducibly discriminate between normal and oxidized RBC. Advanced microfluidic devices could be of clinical value in analyzing populations for hemoglobinopathies or in evaluating donor RBC products post‐storage to assess transfusion suitability. Am. J. Hematol. 88:682–689, 2013. © 2013 Wiley Periodicals, Inc.